Skip to main content
. 2017 May 12;7:1839. doi: 10.1038/s41598-017-02010-w

Figure 2.

Figure 2

Cumulative incidence of clinical relapse according to combining HBV DNA at entry and end-of-treatment HBsAg levels (a) the definition of Group I to IV: as mention Fig. 1a (b) the definition of Group A to C: as mention Fig. 1b.